These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3283094)

  • 1. The use of aztreonam in serious gram-negative infections.
    Smith G; Bunney RG; Farrell ID; Wood MJ
    J Antimicrob Chemother; 1988 Feb; 21(2):233-41. PubMed ID: 3283094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with aztreonam in four Mediterranean countries.
    Daikos GK
    Rev Infect Dis; 1985; 7 Suppl 4():S831-5. PubMed ID: 2934787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of aztreonam therapy for serious infections due to gram-negative bacteria.
    McKellar PP
    Rev Infect Dis; 1985; 7 Suppl 4():S803-9. PubMed ID: 3909340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter comparative trial of aztreonam in the treatment of gram-negative infections in compromised intensive-care patients.
    Rabinad E; Bosch-Perez A
    Chemotherapy; 1989; 35 Suppl 1():1-7. PubMed ID: 2659288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aztreonam.
    Tunkel AR; Scheld WM
    Infect Control Hosp Epidemiol; 1990 Sep; 11(9):486-94. PubMed ID: 2230052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of aztreonam in lower respiratory tract infections.
    Cook JL
    Urology; 1988 Jun; 31(6 Suppl):33-6. PubMed ID: 3287748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Brogden RN; Heel RC
    Drugs; 1986 Feb; 31(2):96-130. PubMed ID: 3512234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aztreonam therapy for serious gram-negative bacillary infections.
    Cone LA; Woodard DR
    Rev Infect Dis; 1985; 7 Suppl 4():S794-802. PubMed ID: 3909339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of aztreonam in gram-negative pneumonia versus a therapeutic regimen that includes an aminoglycoside. Spanish Study Group.
    Marco V; Gobernado M; Santos M; Rabinad E
    Chemotherapy; 1989; 35 Suppl 1():81-8. PubMed ID: 2659295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aztreonam in the treatment of bone and joint infections caused by gram-negative bacilli.
    Simons WJ; Lee TJ
    Rev Infect Dis; 1985; 7 Suppl 4():S783-8. PubMed ID: 2934786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of serious gram-negative infections with aztreonam.
    Greenberg RN; Reilly PM; Luppen KL; McMillian R; Bollinger M; Wolk SM; Darji TB; Noorani AA
    J Infect Dis; 1984 Nov; 150(5):623-30. PubMed ID: 6541672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycosides, imipenem, and aztreonam.
    Johnson JG; Hardin TC
    Clin Podiatr Med Surg; 1992 Apr; 9(2):443-64. PubMed ID: 1586911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of low dose aztreonam in the treatment of moderate to severe gram-negative bacterial infections.
    Clergeot A; Steru D; Rosset MA; Carbon C
    J Antimicrob Chemother; 1989 May; 23(5):753-8. PubMed ID: 2759924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical efficacy of aztreonam in refractory infections in children].
    Ogura H; Hamada F; Fujieda M; Matsumoto K; Araki K; Ogura Y; Kuramitsu M; Kurashige T; Kitamura I
    Jpn J Antibiot; 1985 Nov; 38(11):3349-57. PubMed ID: 4094068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aztreonam in the prevention and treatment of infection in neutropenic cancer patients.
    Rolston KV; Bodey GP; Elting L
    Am J Med; 1990 Mar; 88(3C):24S-29S; discussion 38S-42S. PubMed ID: 2180294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of aztreonam plus clindamycin with tobramycin plus clindamycin in the treatment of intra-abdominal infections.
    Birolini D; Moraes MF; de Souza OS
    Chemotherapy; 1989; 35 Suppl 1():49-57. PubMed ID: 2659290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aztreonam: the first monobactam.
    Neu HC
    Med Clin North Am; 1988 May; 72(3):555-66. PubMed ID: 3280906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
    Scully BE; Neu HC
    Am J Med; 1985 Feb; 78(2):251-61. PubMed ID: 4038574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gram-negative bacillary pneumonia in the nosocomial setting. Role of aztreonam therapy.
    Cook JL
    Am J Med; 1990 Mar; 88(3C):34S-37S; discussion 38S-42S. PubMed ID: 2316557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbapenems and monobactams: imipenem, meropenem, and aztreonam.
    Hellinger WC; Brewer NS
    Mayo Clin Proc; 1999 Apr; 74(4):420-34. PubMed ID: 10221472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.